DURECT Corporation to Participate in Upcoming Healthcare Conferences

Download PDF:

CUPERTINO, Calif., June 6 /PRNewswire-FirstCall/ — DURECT Corporation
(Nasdaq: DRRX) announced today that management is scheduled to present at
three upcoming life sciences conferences in New York, NY.

— Needham & Company’s Biotechnology and Medical Technology Conference on
Thursday, June 12th at 11:30 a.m. EDT.
— Leerink Swann’s Pain Roundtable Conference, on Monday, June 23rd at
12:45 p.m. EDT.
— Jefferies’ 2nd Annual Healthcare Conference on Thursday, June 26th at
10:45 a.m. EDT.

A live audio webcast of the presentations will be available by accessing
DURECT’s homepage at http://www.www.durect.com and clicking “Investor Relations.”
If you are unable to participate during the live webcast, the call will be
archived on DURECT’s website under Audio Archive in the “Investor Relations”

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company
developing pharmaceutical systems based on its proprietary drug delivery
platform technologies. The Company currently has a number of late-stage
pharmaceutical products in development addressing large markets in pain
management, with a number of research programs underway targeting chronic
disease and other therapeutic areas. For more information, please visit

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

CONTACT: Matthew J. Hogan, Chief Financial Officer of DURECT
Corporation, +1-408-777-4936
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: http://www.www.durect.com

Scroll to Top